Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19lm0203005j0003)
Takeda Science Foundation
Received: 22 February 2020
Revised: 19 August 2020
Accepted: 26 August 2020
First Online: 16 September 2020
Ethics approval and consent to participate
: The study protocol was approved by the ethics committee at each participating institution (Institutional Review Board at Nagoya City University Hospital, Institutional Review Board at Nagoya Daini Red Cross Hospital and Ethical Committee at Okazaki Public Health Center), and was conducted according to the ethical guidelines of the Helsinki Declaration of 1964 and later versions. All patients provided written, informed consent prior to enrolment in the study.
: The data that support the findings of this study are available on request from the corresponding author (T.S.).
: The authors declare no competing interests.
: This study was supported, in part, by Japan Agency for Medical Research and Development under Grant Number JP19lm0203005j0003 (to T.S.) and the Takeda Science Foundation (to T.S.).